Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Incyte 1.674, Henry Schein 3.458.
Incyte vs Henry Schein: Revenue Comparison
Incyte (INCY) and Henry Schein (HSIC) are peers in Healthcare. Incyte reported revenue of $1.7B as of Q2 2026, compared with $3.5B for Henry Schein. Henry Schein leads on revenue.
Incyte's gross margin is 93.7% versus 31.8% for Henry Schein. Incyte's net margin is 35.0% versus 2.7% for Henry Schein.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Incyte, Henry Schein.| Metric | Incyte | Henry Schein |
|---|---|---|
| Market Cap | - | - |
| Revenue | $1.67B | $3.46B |
| Cost of Revenue | $105.00M | $2.36B |
| Gross Profit | $1.57B | $1.10B |
| Operating Income | $698.00M | $200.00M |
| Net Income | $586.00M | $94.00M |
| R&D Expense | $517.00M | $0 |
| Earnings Per Share | $2.81 | $0.82 |
| Gross Margin | 93.7% | 31.8% |
| Operating Margin | 41.7% | 5.8% |
| Net Profit Margin | 35.0% | 2.7% |
| Free Cash Flow | $495.00M | $196.00M |
| Cumulative Free Cash Flow | $3.86B | $9.89B |
| Operating Cash Flow | $508.00M | $242.00M |
| Cash & Equivalents | $3.98B | $157.00M |